JA
WST icon

JOYN Advisors’s West Pharmaceutical WST Stock Holding History

JOYN Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-167
Closed -$16K – 1428
2018
Q4 		$16K Sell
167
-27
-14% -$2.93K ﹤0.01% 776
2018
Q3 		$24K Buy
194
+53
+38% +$5.94K ﹤0.01% 631
2018
Q2 		$14K Buy
141
+69
+96% +$6.35K ﹤0.01% 795
2018
Q1 		$6K Buy
+72
New +$6.74K ﹤0.01% 840

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JOYN Advisors's WST Position: Q1 2019 in Review

JOYN Advisors sold out of West Pharmaceutical (WST) in Q1 2019, closing a stake of 167 shares — an estimated $16K sold.

JOYN Advisors first reported a position in WST in Q1 2018 and held it in 4 quarters. The position peaked at $24K in Q3 2018. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

  • JOYN Advisors reported no remaining West Pharmaceutical position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 167 West Pharmaceutical shares in Q1 2019, an estimated $16K.
  • JOYN Advisors first reported a position in West Pharmaceutical in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's West Pharmaceutical position peaked at $24K in Q3 2018.
  • 379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.